{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:37:13Z","timestamp":1790897833640,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jns.2023.120677","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T11:12:32Z","timestamp":1683889952000},"page":"120677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Identifying specific myelopathy etiologies in the evaluation of suspected myelitis: A retrospective analysis"],"prefix":"10.1016","volume":"450","author":[{"given":"Samir","family":"Alkabie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney S.","family":"Casserly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Racosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.120677_bb0005","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1212\/WNL.0000000000004796","article-title":"Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses","volume":"90","author":"Zalewski","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0010","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1212\/WNL.0000000000007828","article-title":"Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology","volume":"93","author":"Sechi","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0015","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1212\/WNL.0000000000004765","article-title":"Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy","volume":"90","author":"Barreras","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0020","article-title":"Bert: pre-training of deep bidirectional transformers for language understanding","author":"Devlin","year":"2018","journal-title":"arXiv preprint"},{"key":"10.1016\/j.jns.2023.120677_bb0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2023.120677_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamaneurol.2018.2734","article-title":"Characteristics of spontaneous spinal cord infarction and proposed diagnostic criteria","volume":"76","author":"Zalewski","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0050","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for Neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group","volume":"75","author":"Stern","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The international criteria for Behcet's disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet's D","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jns.2023.120677_bb0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrneurol.2018.39","article-title":"The current role of MRI in differentiating multiple sclerosis from its imaging mimics","volume":"14","author":"Geraldes","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0065","first-page":"8","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2023.120677_bb0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2023.120677_bb0075","first-page":"143","article-title":"Metabolic and toxic myelopathies","volume":"27","author":"Parks","year":"2021","journal-title":"Continuum (Minneap. Minn.)"},{"key":"10.1016\/j.jns.2023.120677_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.24184","article-title":"Specific pattern of gadolinium enhancement in spondylotic myelopathy","volume":"76","author":"Flanagan","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1212\/CON.0000000000000975","article-title":"Spondylotic and other structural myelopathies","volume":"27","author":"Bhattacharyya","year":"2021","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jns.2023.120677_bb0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/jnnp-2018-318004","article-title":"Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis","volume":"90","author":"Sechi","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2023.120677_bb0100","first-page":"30","article-title":"Vascular myelopathies","volume":"27","author":"Zalewski","year":"2021","journal-title":"Continuum (Minneap. Minn.)"},{"key":"10.1016\/j.jns.2023.120677_bb0105","doi-asserted-by":"crossref","first-page":"519468","DOI":"10.3389\/fneur.2020.519468","article-title":"Revisiting transverse myelitis: moving toward a new nomenclature","volume":"11","author":"Blackburn","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","author":"Transverse Myelitis Consortium Working G","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0115","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0120","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0125","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"534","author":"Guy","year":"1976"},{"key":"10.1016\/j.jns.2023.120677_bb0130","first-page":"62","article-title":"Myelitis and other autoimmune myelopathies","volume":"27","author":"Lopez Chiriboga","year":"2021","journal-title":"Continuum (Minneap. Minn.)"},{"key":"10.1016\/j.jns.2023.120677_bb0135","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/CPJ.0000000000001036","article-title":"Utility of MRI enhancement pattern in myelopathies with longitudinally extensive T2 lesions","volume":"11","author":"Mustafa","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jns.2023.120677_bb0140","doi-asserted-by":"crossref","first-page":"103516","DOI":"10.1016\/j.msard.2022.103516","article-title":"Wilcoxon-Mann-Whitney odds ratio: a statistical measure for ordinal outcomes such as EDSS","volume":"59","author":"Howard","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2023.120677_bb0145","doi-asserted-by":"crossref","first-page":"120425","DOI":"10.1016\/j.jns.2022.120425","article-title":"Identification of specific causes of myelopathy in a large cohort of patients initially diagnosed with transverse myelitis","volume":"442","author":"Murphy","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2023.120677_bb0150","doi-asserted-by":"crossref","first-page":"1011579","DOI":"10.3389\/fneur.2022.1011579","article-title":"Myelitis features and outcomes in CNS demyelinating disorders: comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD","volume":"13","author":"Fadda","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0155","first-page":"1","article-title":"Natural course of untreated spinal cord cavernous malformations: a follow-up study within the initial 5 years after diagnosis","author":"Santos","year":"2021","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.jns.2023.120677_bb0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jnnp-2018-319553","article-title":"Clinical presentation, natural history and outcomes of intramedullary spinal cord cavernous malformations","volume":"90","author":"Goyal","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2023.120677_bb0165","doi-asserted-by":"crossref","first-page":"912050","DOI":"10.3389\/fneur.2022.912050","article-title":"Testing for antibodies against aquaporin-4 and myelin oligodendrocyte glycoprotein in the diagnosis of patients with suspected autoimmune myelopathy","volume":"13","author":"Alkabie","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0170","doi-asserted-by":"crossref","first-page":"e1351","DOI":"10.1212\/WNL.0000000000012599","article-title":"CNS demyelinating attacks requiring ventilatory support with myelin oligodendrocyte glycoprotein or aquaporin-4 antibodies","volume":"97","author":"Zhao-Fleming","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1474-4422(20)30392-6","article-title":"New therapies for neuromyelitis optica spectrum disorder","volume":"20","author":"Levy","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2023.120677_bb0190","doi-asserted-by":"crossref","first-page":"885218","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2023.120677_bb0195","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1212\/WNL.0000000000013087","article-title":"Glial fibrillary acidic protein autoimmunity: a French cohort study","volume":"98","author":"Gravier-Dumonceau","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","article-title":"Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1year","volume":"321","author":"Dubey","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2023.120677_bb0205","first-page":"7","article-title":"Clinical and MRI phenotypes of sarcoidosis-associated myelopathy","author":"Murphy","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2023.120677_bb0210","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1177\/1352458515613642","article-title":"Spinal cord involvement in Behcet\u2019s disease","volume":"22","author":"Lee","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2023.120677_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084605","article-title":"Neurological involvement in primary Sjogren syndrome: a focus on central nervous system","volume":"9","author":"Morreale","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2023.120677_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123953","article-title":"Neurological and inflammatory manifestations in Sjogren\u2019s syndrome: the role of the kynurenine metabolic pathway","volume":"19","author":"de Oliveira","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2023.120677_bb0225","first-page":"235","article-title":"The natural history of cervical spondylotic myelopathy","volume":"66","author":"Sadasivan","year":"1993","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.jns.2023.120677_bb0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1529-9430(02)00556-9","article-title":"Spontaneous regression of herniated cervical disc","volume":"3","author":"Kobayashi","year":"2003","journal-title":"Spine J."},{"key":"10.1016\/j.jns.2023.120677_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.sc.3101265","article-title":"Cytomegalovirus-associated transverse myelitis in a non-immunocompromised patient","volume":"40","author":"Karacostas","year":"2002","journal-title":"Spinal Cord"},{"key":"10.1016\/j.jns.2023.120677_bb0240","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120677_bb0245","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0140-6736(20)32723-9","article-title":"Acute flaccid myelitis: cause, diagnosis, and management","volume":"397","author":"Murphy","year":"2021","journal-title":"Lancet"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23001375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23001375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:01:12Z","timestamp":1758384072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":49,"alternative-id":["S0022510X23001375"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120677","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying specific myelopathy etiologies in the evaluation of suspected myelitis: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120677"}}